FDA Advocacy
Late last night, the FDA announced that, effective immediately, both medication abortion and miscarriage patients would be able to access mifepristone via delivery from their providers or through mail-order pharmacies. This tremendous victory will ensure that patients and providers are protected during the pandemic.
Testimony Delivered to the Vaccines and Related Biological Products Advisory Committee
How safe are the vaccines? How effective? Were they tested in people like me? Was the approval process influenced by political pressure? Here’s what we know.
Testimony Delivered to the Vaccines and Related Biological Products Advisory Committee
Testimony Delivered to the Vaccines and Related Biological Products Advisory Committee
On September 28 — the 20th anniversary of FDA’s approval of the abortion pill — we held a socially distanced protest in front of FDA headquarters and delivered the names of all 12,000+ of our petition signers.
Public comments urging the FDA’s Office of Women’s Health to ensure that women’s needs are represented across FDA and in the agency’s research, education, and public outreach.
Patients are turning to telehealth appointments and online pharmacies for routine medical care during the COVID-19 outbreak without having to leave their homes. But for most pregnant people seeking safe and effective abortion pills, the FDA has created a Byzantine set of rules that delay or block access to care.
The NWHN is calling on the FDA to lift politically motivated, medically unnecessary restrictions on the abortion pill right now and let pregnant people receive the abortion pill through the mail so that they can get the pill where they take the pill, at home.
The FDA says pregnant people can meet with their doctors remotely and have their abortion at home — but first, they must travel during a global pandemic just to pick up their pills.